Clinical trial

Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma

NCT01845038

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE1

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2016-12-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

OTX-TPa ~4µg/day over 2 mos. with natural tears dropsDRUG

OTX-TPb ~3µg/day over 3 months with natural tears dropsDRUG

Timolol Maleate (0.5%) dosed twice daily with punctum plug without drugDRUG

Sponsors & collaborators

Ocular Therapeutix, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01845038 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.